Apcotex Q4 FY26: Margin recovery powers profit growth

Apcotex Industries ended FY26 with a clear shift in financial momentum. While operational revenue rose modestly to INR 14,415 million, profitability improved sharply. EBITDA increased to INR 1,774 million and EBITDA margin expanded to 12.31%. Net profit for the year was INR 1,014 million. In Q4 FY26, the company reported operational revenue of INR 3,976 million, EBITDA of INR 547 million and PAT of INR 347 million, with YoY profit growth crossing 100%.

The company attributed the quarter’s performance to volume growth, pricing discipline, and better operational efficiency. Volumes rose 10% YoY in Q4 and management indicated that demand remained steady across key segments. FY26 also delivered record-high sales volumes and the highest export volume to date, both growing 14% YoY, even as revenue growth remained lower than volume growth due to price movements across the year.

What Apcotex sells and where it plays

Apcotex operates across synthetic latex and synthetic rubber, offering a broad range of emulsion polymers. On the latex side, applications include paper and paper board, carpet, gloves, construction, tyre cord, speciality and textile. On the rubber side, applications include automobile, footwear, rice rolls and other rubber products. The company’s manufacturing footprint includes a latex-heavy Taloja facility (1,03,000 MTPA synthetic latex and 7,000 MTPA high styrene rubber) and a Valia facility with 21,000 MTPA nitrile rubber and allied products and a 50,000 MTPA nitrile latex plant.

In the earnings call, management noted that in Q4 FY26 the company operated at high utilization levels, between 90% and 100% across plants. NBR was described as running at 100% utilization for a few quarters and expected to stay there for the next four quarters until new capacity comes up in Q1 of the following financial year.

Margin recovery and what drove Q4

The quarter saw a meaningful uplift in profitability. EBITDA rose 42.1% YoY and margins improved by 274 bps. Management cited higher volumes, improved realizations and enhanced operational efficiency. The concall added important context: the ongoing West Asia crisis created volatility in raw material prices and moderated export demand in certain markets. In response, the company said it proactively secured key raw materials to avoid customer supply disruptions.

Management also flagged several accounting and provisioning items booked during Q4. Employee benefit expenses included provisions of about INR 14 crores linked to a long-term incentive plan, provisions related to pending litigations based on external legal advice, and higher gratuity and leave encashment obligations arising from policy changes. Separately, impairment of a turbine and related accessories at the Valia facility resulted in an impairment loss of about INR 4 crores, and a revision in useful life assumptions for certain plant and machinery led to additional depreciation of about INR 2 crores during the quarter.

These items were described as largely one-off in nature, with management indicating that a portion (particularly the long-term incentive provisioning) would recur but on a more evenly spread basis going forward.

Nitrile latex: utilization is high, the cycle is still the cycle

Nitrile latex remained a major talking point, largely because of how the segment has behaved since commissioning. Management said nitrile latex margins have improved gradually through FY26 and improved significantly in Q4, but it also emphasized that the industry remains in oversupply. Importantly, it acknowledged that part of the recent margin strength could be temporary because the company was better placed than some competitors during March, allowing it to supply customers more consistently.

The operational takeaway was clear. Management said nitrile latex was running close to full capacity utilization in Q4 and it expects to maintain near 100% utilization going forward. So the immediate lever for earnings is not incremental utilization but the spread between realizations and raw material costs.

Balance sheet strength and cash discipline

Apcotex ended FY26 with a stronger balance sheet. The company’s net debt-to-equity improved to 0.08 in FY26 from 0.27 in FY25. Management stated that the company remained net cash positive, with cash and investments exceeding borrowings by about INR 700 million. On the call, the CFO quantified total debt at around INR 92 crores and cash plus investments at about INR 160-plus crores.

This balance sheet position also supported shareholder payouts. The board announced a final dividend of INR 5.5 per equity share, taking the total dividend for FY26 to INR 8.0 per equity share including the interim dividend.

Capex, capacity additions, and R&D focus

Management indicated that FY27 will not see major capacity expansion coming on stream, though debottlenecking projects may help marginally. Most additional capacity is expected by Q1 of FY28. The company also stated it is continuing with an NBR expansion project that is expected to almost double NBR capacity by next year.

On innovation, management described a push toward specialized grades within end markets and noted that certain niche products are developed for specific customers. It also disclosed board approval to build a new R&D center, with an infrastructure spend of INR 20 to 25 crores.

Key takeaways

FY26 was defined by a meaningful profitability recovery on the back of higher volumes, better utilization, and improved margins. Q4 also benefited from strong execution during a volatile raw material environment, with management emphasizing proactive procurement decisions that helped avoid production disruptions.

At the same time, the call made it clear that near-term conditions remain uncertain. Geopolitical disruptions, raw material price volatility, and export-market competitiveness were highlighted as real variables. With utilization high across plants and major expansions largely timed for FY28, the next phase depends on sustaining spreads, executing capacity additions on schedule, and continuing the shift toward more specialized products through R&D.